The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 21, 2009
Filed:
Oct. 31, 2007
Valentina Molteni, San Diego, CA (US);
Shuli You, Shanghai, CN;
Juliet Nabakka, Santee, CA (US);
Yi Liu, San Diego, CA (US);
Xiaolin LI, San Diego, CA (US);
Donatella Chianelli, San Diego, CA (US);
Jon Loren, San Diego, CA (US);
Xiaodong Liu, San Diego, CA (US);
Shifeng Pan, San Diego, CA (US);
Donald S. Karanewsky, Escondido, CA (US);
Pascal Furet, Thann, FR;
Vito Guagnano, Basel, CH;
Valentina Molteni, San Diego, CA (US);
Shuli You, Shanghai, CN;
Juliet Nabakka, Santee, CA (US);
Yi Liu, San Diego, CA (US);
Xiaolin Li, San Diego, CA (US);
Donatella Chianelli, San Diego, CA (US);
Jon Loren, San Diego, CA (US);
Xiaodong Liu, San Diego, CA (US);
Shifeng Pan, San Diego, CA (US);
Donald S. Karanewsky, Escondido, CA (US);
Pascal Furet, Thann, FR;
Vito Guagnano, Basel, CH;
IRM LLC, Hamilton, BM;
Novartis AG, Basel, CH;
Abstract
Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.